CELLECTIS : Issues Statement Regarding Patent Suits on Meganuclease Technology | 4-Traders

Cellectis SA (Paris:ALCLS), the French genome engineering company, provided an update today regarding its recent patent litigations against Precision Biosciences, Inc. ("Precision"). On November 30th 2010, in the District of Delaware, Cellectis brought suit against Precision for infringement of Cellectis's U.S. Patent No. 7,842,489. Shortly thereafter, on March 1st, 2011, Cellectis brought a second suit against Precision...